chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approx. 4 hours after injection, I experienced terrible arm pain at injection site. Now 24 hours later, it's still there just not as bad.   Approx. 12 hours after injection, I developed upper left abdomen pain which also happened last time with injection #2  Approx. 24 hours after injection, along with the abdomen pain, I developed diarrhea which also happened last time with injection #2 (in which I needed to go to the hospital & colitis had been found - no previous colitis & everything resolved in a month or so).  Now approx. 28 hours after injection, the upper left abdomen pain is tolerable but the diarrhea is persistent.
fever 101 29APR92 & 30APR92; rt parotitis 12MAY92;
Heart flutters; Heart palpitations; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC FLUTTER (Heart flutters) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety.    On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On an unknown date, the patient experienced CARDIAC FLUTTER (Heart flutters) (seriousness criterion medically significant) and PALPITATIONS (Heart palpitations). At the time of the report, CARDIAC FLUTTER (Heart flutters), PAIN IN EXTREMITY (Sore arm) and PALPITATIONS (Heart palpitations) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Patient was asking if she should  get her 2nd shot on Aug 31st.  Patient has an appointment with a new primary care physician on 4Sep2021 and wants to know if she can extend the shot after that. No treatment information was provided.  Company Comment: Based on the current available information and temporal association between the use of the product mRNA-1273 and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product mRNA-1273 and the start date of the events, a causal relationship cannot be excluded.
Patient vaccinated with Moderna COVID vaccine 3/25/21 and 4/22/21.  Patient presented to Hospital 4/29 with SOB.  The patient actually stated the SOB started 4/21 and he received his second Moderna vaccination 4/22.  SOB progressively worsened from 4/21 until ED visit.  Patient thought it was asthma flare.  4/29 04:00 CTA chest showing extensive bilateral pulmonary emboli, left greater than right. Started on heparin protocol for PE in the ER.  4/29 afternoon, patient is currently an inpatient at GSH on a heparin drip for anticoagulation.
Heaviness in legs with muscle tightness/soreness, slight temporal headache, sore L UE at injection site, some nausea later in the day.
Fever 12/18/07, seizure 12/18/07, ITP onset 1/3/08. Platelet count < 5,000 1/4/08-1/6/08. Anti-D given 1/4/08. As of 1/11/08, platelet count up to 356,000.
Pt c/o Numbness in Left arm at deltoid radiating down arm. Sharp, pain when raising arm. Only able to raise arm shoulder-high. Also pain in triceps when she bends arm. Pt states problem hasn't resolved since administration of vaccine. Has not sought medical care. Has taken OTC ASA for s/sx with some relief, but not total resolution.
3/26/2021 she received the  2nd Moderna dose.  She reports alternating  feeling freezing cold and sweating through out the first night, hurting in every joint, headache.  She also had approx 10 episodes of  heart palpitations or flutters over 8 hours.   She was eval in Urgent Care on 3/27/2021.   Toradol was administered.   She also noticed "a little bit of shortness of breath".   She used her rescue inhaler, which improved her breathing.    At the time of this report, she states some improvement, but symptoms not resolved.  She has had 7 episodes of palpitations today.
SEIZURES; OTHER HEALTH PROBLEMS; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  It was reporter that "my granddaughter had seizures and other health problems with the shots". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the seizures and other health problems was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0- 20220253674-covid-19 vaccine ad26.cov2.s-Seizure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
Patient with abdominal pain, diarrhea, and intractable nausea and vomiting beginning about 3 hours after receiving IZ.  Seen in clinic today and RXd zofran and scopalamine.
Just moved here - came to get school cert - got TDAP, Varicella & mening - he is hyperglycemic & has hyperthyroidism. Fever 103 this morning - gave TYLENOL - ice pack on Rt arm - states it hurts - not swollen has appt 9-22-10 with Dr.
pt had fever of 104 noted by parents of AM of 30AUG; pt treated w/APAP q 4 hrs for fever; pt exp 2 episodes of sz; 1 episode on evening of 30AUG & one episode 31AUG; parents brought pt to ER 31AUG
Four minutes after his vaccination, patient reported feeling "hot", and sweating profusely.  Some shortness of breath, and mild chest pain. Patient was responsive, and able to answer questions. By 2:50 PM, pt reported feeling "better" but still "groggy".
His father stated that his "arm is sore."  No other adverse effects noted, 5-13-09.
extreme Upper GI distress/ extreme GI distress; Painful gas/ gas pains; Bloating; Sharp stabbing pain on left side rib cage, with each inspiration.; Sharp stabbing pain on left side rib cage, with each inspiration/ Could only take shallow breaths to temper the pain; the pain on the right side is much worse when sleeping/ Difficult to find any position to sleep/ could not find a position to sleep in; This is a spontaneous report received from a contactable health care professional (patient) and consumer (patient's mother). A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN6260), via unspecified route of administration in left arm on 09Mar2021 09:30 AM as 2nd dose, single dose for COVID-19 immunization. The patient was not pregnant at the time of event and at the time of vaccination. The patient's medical history was not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient's concomitant medications included levothyroxine sodium (SYNTHROID), from unspecified date. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL9264), via unspecified route of administration in left arm on unspecified date in Feb2021 02:00 PM (at the age of 71-year-old) for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On the day after second dose (10May2021 07:00 PM) the patient experienced extreme upper gastrointestinal (GI) distress beginning around 7 PM in the evening. Very painful gas and bloating. Sharp stabbing pain on left side rib cage, with each inspiration. She could only take shallow breaths to temper the pain. Difficult to find any position to sleep. Seven days later, still have residual pain. Daughter (patient) provided her adverse event (AE) symptoms and then handed the phone over to her mother. Mother (caller) stated that she had her second dose of the Pfizer Covid-19 vaccine on 09Mar2021. Caller reported that on 10Mar2021 at 7 o clock that she had extreme GI distress, bloating and gas pains. Caller reported she could not take deep breaths which caused pains on the left side. Caller stated she could not find a position to sleep in. Caller reported the pain on the right side was much worse when sleeping. Caller stated that seven days later she had improved some. Caller wanted to know if these are reported side effects. It was unknown if treatment was received due to the event. The events resulted in doctor or other healthcare professional office/clinic visit. The case was reported as non-serious. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was resolving.  No follow-up attempts are needed. No further information is expected.
I noticed my breathing was getting labored and my O2 was going down and my temperature was going up. I called the EMTs. They came and did tests on me such as blood pressure etc. They said I was going to be okay. Things subsided after that. I was only having issues for about 3-4 hours. I attempted to take a nebulizer, but it did not seem to have any effect.
Chest/side pain on left side of abdomen comes and goes; shooting pain started about 5 minutes after vaccination. Blood pressure 162/85 after 10 minutes 167/91 after another 10 minutes 157/91. MD called advised ER if pain, patient declined, patient left called at 3 pm, patient ok.
Pt recvd 2 doses of Engerix-B & OCT90 exp a rash on arms & chest 18-24 hrs p/1st dose; NOV90 exp a more extensive rash progressive in severity on chest & limbs & flu-like synd p/2nd dose;
3 days after second vaccination of hep B series, I had vertigo, severe headache and difficulty concentrating all at once. Also had frequent urination.  Nurse follow ups 05/25/04 states: off balance, Head pain increased, Photophobia, Phonophobia, Poor concentration, Irritability, Lethargy, Migraine. Per annual report-I continue to have daily dizzy spells and lighheadedness.  I still have irregular heartbeat and 'periodic' drops in blood pressure causing me to nearly faint.  Because of vaccine, entire life has changed for the worse.  I have to take 2 medications on a daily basis to achieve stability.  This is sad.
3/11/21-post vaccination, slight SOB, substernal chest pain 'burning', vision blurred, O2-4lpm/NC, SaO2 99%, VS WNL- BP 152/80, HR 84, assessment completed pt remained stable throughout. Ct requested to be transported to the hosp, ct states in ER, post vaccination, was given epi, s/s resolved in 2-3hrs, ct decided to not get the 2nd dose due to her reaction.
pt reports pain lt deltoid, body weakness, SOB, neck pain, hot flush/fever, thick mucous in the throat;took advil feels better;pt called MD & plans to see him;
Immediately and for three weeks following the vaccine: Dull headache with low grade fever, hair thinning (loss), abnormal fatigue, muscle leg cramps (dehydration due to fever?) all these have lasted the three weeks since the vaccine.
Headache; Low grade fever; Muscle aches; Initial information was received on 10-Oct-2020 regarding an unsolicited valid non-serious social media case from a consumer via.  This case involves patient with unknown demography who experienced headache (headache), low grade fever (pyrexia) and muscle aches (myalgia), while he/she received INFLUENZA VACCINE.  Medical history, past medical treatments, vaccinations, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (Produced by unknown manufacturer, lot number and expiration date not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a headache, low grade fever (pyrexia) and muscle aches (myalgia), unknown latency following the administration of INFLUENZA VACCINE.  Laboratory data was not reported.   It was not reported if the patient received any corrective treatment or not.  The outcome of the events was unknown at the time of reporting.  There will be no information on the batch number for this case.
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  The reporter reported that because their facility had not been able to download the digital data logger, they had been put on hold by the State at the moment and cannot administer the Moderna COVID-19 vaccine to patients until an assessment by the state was made. There had been no power outages that would have impacted the Moderna vaccine. However, the reporter reiterated that because the facility was unable to download the digital data logger, this issue was treated as a temperature excursion. The reporter was unable to download the data logger for the months of December 2021, January 2022 and February 2022. The reporter was filling out a temperature excursion assessment with the State.   The reporter mentioned that the patient had been administered dose while the temperature excursion assessment was ongoing. No adverse reactions were reported by the patient.  No treatment information was provided by the reporter.
Heart pumping too fast at 110-120 bpm while resting. Normal observed 76-80 before vaccination. Very sharp sudden heart pain. Sweating, fatigue, persistent fever.
This spontaneous report was received from a physician, via company representatives and from a support services director, concerning to a patient of unknown age and gender. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On 26-FEB-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 10 single Ds 0.5 ml Vls  10 SDV (lot number and expiration date: K007262 and 25-NOV-2015 respectively; route of administration was not provided). The vaccine had an excursion of 27 degrees Fahrenheit (-2.77 degrees Celsius) (lowest recorded temperature) for 1380 hours (sum of hours in excursion). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: CAREGIVER REPORTED PATIENT STOPPED EATING AND HAD FEVER OF 101, FEVER WENT DOWN AFTER A DAY OR SO BUT CONTINUED NOT TO EAT-Severe, Additional Details: CAREGIVER REPORTED PT HAD FEVER AND LOSS OF APPETITE AFTER FIRST DOSE, QUESTIONED IF SECOND DOSE IS APPRORPIATE. PER THE CDC GUIDELINES THE PATIENT DID NOT HAVE A SEVERE ALLRGIC REACTON TO THE VACCINE AND THEREFOR SHOULD PROCEED WITH SECOND DOSE. CAREGIVERS STATES TOOK A WHILE FOR PT TO REGAIN APPETITE AFTER THE FIRST DOSE. SECOND DOSE HE HAD FEVER OF 101 FOR ABOUT 1 DAY BUT LOST APPETITE AND NEVER REGAINED. PASSED AWAY ON THE 24TH OF MARCH. CAREGIVER STATES PT WAS \"STRIVING\" PRIOR TO 2ND DOSE
Slight to medium ringing in ears, head feels 'heavy' 'clogged', phantom headache lasts about 10sec.-1min.
LEFT ARM LYMPH NODE SWOLLEN; ARM IS WARM TO THE TOUCH; REDNESS AT INJECTION SITE; TENDERNESS OF LYMPH NODES; FEVER; BODY ACHES; CHILLS; SORE ARM; This spontaneous report received from a patient concerned a 46 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non-alcohol user, and smoker, and other pre-existing medical conditions included no known allergies and no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821286 expiry: UNKNOWN) dose was not reported, administered on 24-JUN-2021 for prophylactic vaccination. No concomitant medications were reported On 24-JUN-2021, the subject experienced sore arm. On 25-JUN-2021, the subject experienced body aches. On 25-JUN-2021, the subject experienced chills. On 25-JUN-2021, the subject experienced fever. On 01-JUL-2021, the subject experienced arm is warm to the touch. On 01-JUL-2021, the subject experienced tenderness of lymph nodes. On 01-JUL-2021, the subject experienced redness at injection site. On an unspecified date, the subject experienced left arm lymph node swollen. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, sore arm, and fever on 25-JUN-2021, was recovering from tenderness of lymph nodes, and left arm lymph node swollen, and had not recovered from redness at injection site, and arm is warm to the touch. This report was non-serious.
Gave vaccine, within 2 minutes patient was clutching at his throat and lips saying that he couldn't breathe, that throat was closing. He was acting unresponsive. Gave epi-pen in left thigh, pulse was good, Paramedics arrived, BP was 140/84. Parent opted not to take him to hospital. He sat in a chair for 30 minutes and seems to recover, was smiling and walking when he left the building. Called mom to check on him the day after on 8/8/21 and she said he was doing fine.
Maculopapular confluent scaly rash-referred pt to a dermatologist.
SWELLING, APPROX 20MM REACTION, REDNESS. FEELS LIKE "WORMS ARE EATING AWAY THE INSIDE OF (HIS) ARM".
Swelling, redness and aching at injection site, spreading from top of the shoulder to halfway down to the elbow.  Headache, body aches and nausea also present.
Sharp, burning stabbing pain in the back of right arm just above the crease of the arm pit. Started at 10pm on Sunday 03/28/21, has not subsided. Comes and goes is not a constant pain. But when it comes it is very painful.
No Adverse effects Noted. Resident administered expired Moderna vaccine, expiration date  10/13/2021.
Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/13/2021 and 2/2/2021. Patient presented to ED on 9/9/2021 for shortness of breath, diagnosed with COVID-19 on 9/5/21 which was onset of his symptoms, including fever to 101, productive cough with white sputum, no hemoptysis. Hospitalized for COVID pneumonia and diabetic ketoacidosis. Azithromycin, ceftriaxone, dexamethasone, fludrocortisone, hydrocortisone, meropenem, micafungin, zosyn, vancomycin were administered. Patient required mechanical ventilation upon admission. Patient continued to decompensate throughout hospitalization and expired at 12:18pm on 9/18/2021.
vaccine reaction. Recieved Jansen COVAX Monday, since has had bodyaches, HA, "feels foggy", runny nose. requesting quarters to rest.  26 yo M, no known chronic medical conditions, p/w malaise, frontal HA, myalgias, mildly runny nose, occasional dry cough that started 12h after receiving J&J COVID vaccine on Monday. No changes to sx since initial onset. Came to ED for quarters.   No SOB, CP, LH, n/v/d, abd pain, dysuria, hematuria, or any other sx.
Pt had symptoms of hives all over body, high temperature and itching for 4 days. Treated with Benadryl and Oraphed 7.5mg bid. Severe allergic reaction to vaccines.
Client received IPV #2 on 08/26/2005 around 09:13AM, by 21:30 client developed fever of 102.4 degrees, stuffy nose, itchy/puffy face and wouldn't talk.  Treated with Tylenol, at 03:00 on 08/27 temperature all day, again treated with Tylenol.  On Saturday, 08/27, low grade temperature all day, itchy/puffy subsided.  Highest temperature 102 degrees that night, no treatment, other than restlessness and irritable throughout rest of Saturday and Sunday.  Fever subsided by 08/28.
This spontaneous report was received from a phlebotomist and refers to an unspecified patient of unknown age and gender. The patient's pertinent medical history, drug reactions and allergies and concomitant therapy were not reported. The phlebotomist reported that the patient received GARDASIL 9 outside the recommended dosing schedule. On an unspecified date in 2013, the patient received the first dose of GARDASIL 9 (dose, route of administration, lot # and expiration date were not reported). On 05-APR-2015 and 15-JUN-2015, the patient was vaccinated with the second and the third dose of GARDASIL 9 (dose and route of administration were not reported, lot # reported as K009902, expiration date 06-MAR-2017), respectively. No adverse effects were reported. Additional information has been requested.
Information has been received from a physician concerning a female patient who on an unknown date was vaccinated with the first dose of GARDASIL (Lot # and expiration not reported). Physician reported that following the injection of GARDASIL the patient was getting up to sit in another area when the patient fainted. The patient sought medical attention. It was reported that the patient received ice for her face. At the time of reporting the outcome of the patient was unknown. Additional information has been requested.